(AFX UK Focus) 2009-12-01 15:34 Russia Stem Cell firm sees IPO at low end of range
MOSCOW, Dec 1 (Reuters) – Russia’s Human Stem Cell Institute will raise around 140 million roubles ($4.80 million) at its upcoming IPO after avgreeing to sell shares at the lower end of its price range, the company said on Tuesday. The Moscow-based biotech said in a statement the shares would be sold at 9.5 roubles a share, within an expected price range of 9-11 roubles a share. A source close …
[Read the full article here]Related News:
(AFX UK Focus) 2009-12-11 06:38 Russia Stem Cell Institute raises $4.6 mln in IPO
JSC "Human Stem Cell Institute" Announces IPO Price Range for Initial Public Offering
Russia Stem Cell Institute raises $4.6 mln in IPO